Satsuma Pharmaceuticals, Inc. Operating Expenses
Satsuma Pharmaceuticals, Inc. reported Operating Expenses of $10.77 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-05-11
- Satsuma Pharmaceuticals, Inc. operating expenses for the quarter ending 2023-03-31 was $10.77M, a 30.73% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. operating expenses for the quarter ending 2022-12-31 was $23.59M, a 51.62% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. operating expenses for the quarter ending 2022-09-30 was $15.41M, a 15.60% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. operating expenses for the quarter ending 2022-06-30 was $16.40M, a 38.68% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. operating expenses for fiscal 2022 was $70.95M, a 38.66% increase from fiscal 2021.
- Satsuma Pharmaceuticals, Inc. operating expenses for fiscal 2021 was $51.17M, a 5.87% increase from fiscal 2020.
- Satsuma Pharmaceuticals, Inc. operating expenses for fiscal 2020 was $48.33M, a 67.33% increase from fiscal 2019.
- Satsuma Pharmaceuticals, Inc. operating expenses for fiscal 2019 was $28.88M, a 284.31% increase from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-03-31 | $10.77M 10-Q · filed 2023-05-11 | $34.36M derived: sum of 2 quarters · filed 2023-05-11 | $49.77M derived: sum of 3 quarters · filed 2023-05-11 | $66.17M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $23.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $39.00M derived: sum of 2 quarters · filed 2023-03-28 | $55.40M derived: sum of 3 quarters · filed 2023-03-28 | $70.95M 10-K · filed 2023-03-28 |
| 2022-09-30 | $15.41M 10-Q · filed 2022-11-03 | $31.81M derived: sum of 2 quarters · filed 2022-11-03 | $47.35M 10-Q · filed 2022-11-03 | $62.91M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | $16.40M 10-Q · filed 2022-08-09 | $31.95M 10-Q · filed 2022-08-09 | $47.51M derived: sum of 3 quarters · filed 2023-05-11 | $60.84M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | $15.55M 10-Q · filed 2023-05-11 | $31.11M derived: sum of 2 quarters · filed 2023-05-11 | $44.44M derived: sum of 3 quarters · filed 2023-05-11 | $56.26M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $15.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $28.89M derived: sum of 2 quarters · filed 2023-03-28 | $40.72M derived: sum of 3 quarters · filed 2023-03-28 | $51.17M 10-K · filed 2023-03-28 |
| 2021-09-30 | $13.33M 10-Q · filed 2022-11-03 | $25.16M derived: sum of 2 quarters · filed 2022-11-03 | $35.61M 10-Q · filed 2022-11-03 | $48.09M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $11.83M 10-Q · filed 2022-08-09 | $22.28M 10-Q · filed 2022-08-09 | $34.76M derived: sum of 3 quarters · filed 2022-08-09 | $46.93M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $10.45M 10-Q · filed 2022-05-10 | $22.94M derived: sum of 2 quarters · filed 2022-05-10 | $35.11M derived: sum of 3 quarters · filed 2022-05-10 | $46.61M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $12.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $24.66M derived: sum of 2 quarters · filed 2022-03-15 | $36.16M derived: sum of 3 quarters · filed 2022-03-15 | $48.33M 10-K · filed 2022-03-15 |
| 2020-09-30 | $12.17M 10-Q · filed 2021-11-09 | $23.67M derived: sum of 2 quarters · filed 2021-11-09 | $35.84M 10-Q · filed 2021-11-09 | $47.12M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $11.50M 10-Q · filed 2021-08-10 | $23.67M 10-Q · filed 2021-08-10 | $34.95M derived: sum of 3 quarters · filed 2021-08-10 | $43.42M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $12.17M 10-Q · filed 2021-05-11 | $23.45M derived: sum of 2 quarters · filed 2021-05-11 | $31.92M derived: sum of 3 quarters · filed 2021-05-11 | $38.34M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $11.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $19.75M derived: sum of 2 quarters · filed 2021-03-25 | $26.17M derived: sum of 3 quarters · filed 2021-03-25 | $28.88M 10-K · filed 2021-03-25 |
| 2019-09-30 | $8.47M 10-Q · filed 2020-11-10 | $14.89M derived: sum of 2 quarters · filed 2020-11-10 | $17.61M 10-Q · filed 2020-11-10 | $19.89M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $6.42M 10-Q · filed 2020-08-11 | $9.14M 10-Q · filed 2020-08-11 | $11.42M derived: sum of 3 quarters · filed 2020-08-11 | $13.02M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $2.71M 10-Q · filed 2020-05-12 | $5.00M derived: sum of 2 quarters · filed 2020-05-12 | $6.60M derived: sum of 3 quarters · filed 2020-05-12 | |
| 2018-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $3.88M derived: sum of 2 quarters · filed 2020-03-10 | $7.51M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $1.60M 10-Q · filed 2019-11-12 | $5.23M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $4.95M 10-K · filed 2020-03-10 |